GlassScriptPhysician profile
Pranay C Patel
NPI 1467423673
$4,499.40
in general payments reported to CMS, 2019-2025
24 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,237 · 2020: $55.07 · 2021: $16.01 · 2022: $17.93 · 2023: $282 · 2024: $542 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,173.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $2,975.74 | 2019-2020 | |
| Aerin Medical INC. | $199.17 | 2019-2025 | |
| Medtronic, INC. | $132.22 | 2024 | Nuvent, Propel, Sinuva |
| Genzyme Corporation | $127.32 | 2021-2024 | |
| Genentech USA, INC. | $118.84 | 2019 | |
| Abbvie INC. | $97.07 | 2023-2025 | |
| Acclarent, INC | $95.07 | 2023-2024 | Trudi Nav Cable |
| Stryker Corporation | $94.21 | 2019 | |
| Integra Lifesciences Corporation | $85.51 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Regeneron Healthcare Solutions, INC. | $83.45 | 2023-2024 | Dupixent |
| Neurent Medical Limited | $75.20 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Glaxosmithkline, LLC. | $73.38 | 2023-2025 | Nucala |
| Phathom Pharmaceuticals, INC. | $58.89 | 2025 | Voquezna |
| Hikma Pharmaceuticals USA | $49.17 | 2023-2024 | Ryaltris |
| Inspire Medical Systems, INC. | $38.80 | 2024 | Inspire |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $29.22 | 2020-2022 | |
| Optinose US, INC. | $28.40 | 2025 | |
| Hologic Sales and Service, LLC | $25.26 | 2023 | Thinprep 2000 Processor, Aptima |
| Phadia US INC. | $24.20 | 2024 | Immunocap |
| Allergan, INC. | $21.66 | 2019 | |
| Aclaris Therapeutics, INC. | $19.91 | 2019 | |
| Amgen INC. | $18.19 | 2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $17.18 | 2019 | |
| Checkpoint Surgical, INC | $11.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pranay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.